- 6
- 0
- 约3.48万字
- 约 8页
- 2017-05-16 发布于上海
- 举报
Bisphosphonates and risk of atrial fibrillation a meta-analysis
Kim et al. Arthritis Research Therapy 2010, 12:R30
/content/12/1/R30
RESEARCH ARTICLE
Open Access
Bisphosphonates and risk of atrial fibrillation: a Research article
meta-analysis
Seo Young Kim*1,2, Min Jung Kim3, Suzanne M Cadarette4 and Daniel H Solomon1,2
Abstract
Introduction: Bisphosphonates are the most commonly used drugs for the prevention and treatment of osteoporosis.
Although a recent FDA review of the results of clinical trials reported no clear link between bisphosphonates and
serious or non-serious atrial fibrillation (AF), some epidemiologic studies have suggested an as
您可能关注的文档
- Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis.doc
- Biomarkers for late-onset neonatal sepsis.doc
- Biology of RANK, RANKL, and osteoprotegerin.doc
- Biomarkers for early diagnosis of AKI in the ICU ready for prime time use at the bedside.doc
- Biomarker profiles in serum and saliva of experimental Sj?gren's syndrome associations with specific autoimmune manifestations.doc
- Biomarker metabolites capturing the metabolite variance present in a rice plant developmental period.doc
- Biomarker Discovery by Novel Sensors Based on Nanoproteomics Approaches.doc
- Biologically induced mineralization of dypingite by cyanobacteria from an alkaline wetland near Atlin, British Columbia, Canada.doc
- Biomarkers in chronic adult hydrocephalus.doc
- Biomarkers in combination they may do better.doc
原创力文档

文档评论(0)